
Leigh Nelson
Articles
-
1 week ago |
multiplesclerosisnewstoday.com | Steve Bryson |Margarida Maia |Andrea Lobo |Leigh Nelson
A single 600 mg dose of Briumvi (ublituximab-xiiy) — instead of the approved 150 mg initial dose plus a 450 mg dose two weeks later — was well tolerated by adults with relapsing forms of multiple sclerosis (MS). That’s according to new data from the ENHANCE Phase 3b clinical trial (NCT05877963), which is evaluating the safety and efficacy of a modified treatment regimen of Briumvi.
-
1 week ago |
multiplesclerosisnewstoday.com | Leigh Nelson |Patricia Inacio |Lindsey Shapiro
In recent months, I’ve attended a couple events in large stadiums. Last December, I went to the Music City Bowl college football game in Nashville, Tennessee, where Mizzou (the University of Missouri) beat the Iowa Hawkeyes. I also saw a Justin Timberlake concert at the T-Mobile Center in Kansas City, Missouri. Both events were great experiences for my family — except for my fear of falling.
-
2 weeks ago |
multiplesclerosisnewstoday.com | Kevin Byrne |Leigh Nelson |Marisa Wexler
I remember the day of my relapsing-remitting multiple sclerosis diagnosis, when I didn’t understand the weight of what I’d been told. I was only 17 years old and didn’t know what questions to ask, what the future held, or what I should’ve felt after hearing those words. Aside from feeling scared, overwhelmed, and numb, I just knew that I wanted to be OK. Looking back, here’s what I wish someone had told me that day, and in the days and months that followed.
-
1 month ago |
multiplesclerosisnewstoday.com | Margarida Maia |Leigh Nelson |Marisa Wexler
More Stamina, a gamified mobile app, helped a small group of people with multiple sclerosis (MS) better manage their fatigue by becoming more aware of their energy levels and planning their activities more effectively, according to a study from Finland. “Fatigue is an invisible but life-altering symptom of MS,” Guido Giunti, MD, PhD, a digital health expert at the University of Oulu who led the More Stamina project and is the study’s lead author, said in a university news story.
-
1 month ago |
multiplesclerosisnewstoday.com | Marisa Wexler |Lindsey Shapiro |Esteban Cerezo |Leigh Nelson
Artificial intelligence (AI) platforms did better than most neurologists at answering a 20-question assessment about multiple sclerosis (MS) in a recent study, suggesting that AI may be a helpful tool for MS care. Neurologists with an MS specialty scored as well, on average, as the AI platforms, while neurology residents with less than two years of training had the lowest scores.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →